Skip to main content
. 2019 Jun 6;14(6):e0217866. doi: 10.1371/journal.pone.0217866

Fig 2. Comparison of immunoreactivity, in IgG ELISA using SAG2-GRA1-ROP1, SAG2-GRA1-ROP1-AMA1N, AMA1N-SAG2-GRA1-ROP1, AMA1C-SAG2-GRA1-ROP1, and AMA1-SAG2-GRA1-ROP1 chimeric proteins, as well as TLA, with sera from patients with suspected acute (I) and chronic T. gondii infection (IIA–IgG titer >300 IU/ml, IIB–IgG titer between 101–300 IU/ml, and IIC IgG titer ≤100 IU/ml), and from seronegative individuals (III).

Fig 2

The horizontal lines represent the cut-off values.